Ovid Therapeutics Stock Price on December 4, 2024
| OVID Stock | USD 0.97 0.02 2.11% |
Below is the normalized historical share price chart for Ovid Therapeutics extending back to May 05, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ovid Therapeutics stands at 0.97, as last reported on the 26th of December, with the highest price reaching 1.02 and the lowest price hitting 0.93 during the day.
If you're considering investing in Ovid Stock, it is important to understand the factors that can impact its price. Ovid Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0756, which implies the firm had a -0.0756% return per unit of risk over the last 3 months. Ovid Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ovid Therapeutics' Risk Adjusted Performance of (0.03), coefficient of variation of (2,295), and Variance of 11.49 to confirm the risk estimate we provide.
The current year's Stock Based Compensation To Revenue is expected to grow to 19.53, whereas Total Stockholder Equity is forecasted to decline to about 83.4 M. . At present, Ovid Therapeutics' Price Book Value Ratio is projected to drop based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 3.82, whereas Price Earnings To Growth Ratio is projected to grow to (3.01). Ovid Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of May 2017 | 200 Day MA 1.7487 | 50 Day MA 1.1338 | Beta 0.41 |
Ovid |
Sharpe Ratio = -0.0756
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OVID |
Estimated Market Risk
| 3.37 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ovid Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ovid Therapeutics by adding Ovid Therapeutics to a well-diversified portfolio.
Price Book 0.8994 | Enterprise Value Ebitda (0.69) | Price Sales 108.6234 | Shares Float 46.5 M | Wall Street Target Price 3.26 |
Related Headline
Karyopharm Therapeutics Headline on 4th of December 2024
Disposition of 3620 shares by Paulson Richard A. of Karyopha... by thelincolnianonline.com
Filed transaction by Karyopharm Therapeutics Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Ovid Therapeutics Valuation on December 4, 2024
It is possible to determine the worth of Ovid Therapeutics on a given historical date. On December 4, 2024 Ovid was worth 1.07 at the beginning of the trading date compared to the closed value of 1.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ovid Therapeutics stock. Still, in general, we apply an absolute valuation method to find Ovid Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ovid Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ovid Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.12 | 1.13 | 1.08 | 1.10 | 155,934 | |
12/04/2024 | 1.07 | 1.11 | 1.03 | 1.06 | 199,188 |
| 1.05 | 1.10 | 1.01 | 1.03 | 165,258 |
| Backtest Ovid Therapeutics | | | Ovid Therapeutics History | | | Ovid Therapeutics Valuation | Previous | Next |
Ovid Therapeutics Trading Date Momentum on December 4, 2024
| On December 05 2024 Ovid Therapeutics was traded for 1.03 at the closing time. The top price for the day was 1.10 and the lowest listed price was 1.01 . The trading volume for the day was 165.3 K. The trading history from December 5, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.83% . The trading delta at closing time against the current closing price is 2.83% . |
Ovid Therapeutics Fundamentals Correlations and Trends
By evaluating Ovid Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ovid Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ovid financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ovid Therapeutics Stock history
Ovid Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ovid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ovid Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ovid Therapeutics stock prices may prove useful in developing a viable investing in Ovid Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 70.6 M | 44 M | |
| Net Loss | -62.3 M | -59.2 M |
Ovid Therapeutics Quarterly Net Working Capital |
|
Ovid Therapeutics Stock Technical Analysis
Ovid Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ovid Therapeutics Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Ovid Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ovid Therapeutics December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Ovid Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ovid Therapeutics shares will generate the highest return on investment. By undertsting and applying Ovid Therapeutics stock market strength indicators, traders can identify Ovid Therapeutics entry and exit signals to maximize returns
Ovid Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ovid Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Ovid Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ovid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.30) | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ovid Stock analysis
When running Ovid Therapeutics' price analysis, check to measure Ovid Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ovid Therapeutics is operating at the current time. Most of Ovid Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ovid Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ovid Therapeutics' price. Additionally, you may evaluate how the addition of Ovid Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |